Market Performance of Larimar Therapeutics (LRMR)
Larimar Therapeutics (ticker: LRMR) experienced a decline of 0.82 % during the 24‑hour period ending at 12:55 PM Central Europe on Thursday, 22 October 2026.
- Current trading price: USD 2.42 per share on major exchanges.
- Shares outstanding: 104.4 million.
- Market capitalization: USD 254.7 million.
- Volume in the last 24 hours: USD 3.7 million worth of shares exchanged.
- Year‑to‑date performance: The stock has fallen 36.65 % since the end of the previous month.
- 200‑day simple moving average: USD 3.84.
- 52‑week range: The highest price reached USD 6.42 on 25 February 2026; the lowest price recorded USD 1.92 on 16 October 2026.
Comparison with Related Stocks (24‑Hour Performance)
| Company | Ticker | 24‑Hour Change | Current Price | Market Capitalization | Key Metric |
|---|---|---|---|---|---|
| Friedman Industries | FRD | Down 1.06 % | USD 42.05 | USD 303.3 million | P/E 12.59 |
| Cs Disco | LAW | Up 2.57 % | USD 4.79 | USD 303.2 million | – |
| Highview Merger | HVMC | Flat 0 % | USD 10.29 | USD 302.6 million | – |
| Sanara Medtech | SMTI | Down 1.12 % | USD 32.77 | USD 304.5 million | – |
| Benitec Biopharma | BNTC | Down 5.97 % | USD 8.50 | USD 303.5 million | – |
Company Overview
Larimar Therapeutics, Inc. is a biotechnology firm focused on the development and discovery of treatments for rare complex diseases, including protein replacement therapy. The company operates within the health care sector and is headquartered in Bala Cynwyd, United States, primarily serving customers in Pennsylvania. Additional information can be found on the company’s website at www.larimartx.com or by trading its shares on the Nasdaq exchange.
